...
首页> 外文期刊>Expert opinion on biological therapy >A review of current progress in gene and stem cell therapy for erectile dysfunction.
【24h】

A review of current progress in gene and stem cell therapy for erectile dysfunction.

机译:基因和干细胞治疗勃起功能障碍的最新进展综述。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Current gene-based strategies for treatment of erectile dysfunction (ED) are based on the nitric oxide (NO)/cGMP system; although growth factors, calcium sensitization, and potassium channel expression have been studied. Initial investigations of stem-cell-based therapy have attracted attention. Results of the first gene transfer clinical trial for treatment of ED with maxi-K channels are positive. Moreover, there is progress in gene and stem-cell therapy for the treatment of cardiovascular (CV) diseases. OBJECTIVE: To improve understanding of gene and stem-cell therapy for CV disease, with emphasis on ED. Methods: Review of current literature. RESULTS/CONCLUSION: Treatment and prevention of ED can be improved by the application of CVD gene/cell-based therapy. New discoveries based on gene- and cell-based therapy will lead to new advances in the treatment of ED.
机译:背景:目前基于基因的勃起功能障碍(ED)治疗策略是基于一氧化氮(NO)/ cGMP系统。尽管已经研究了生长因子,钙敏化和钾通道表达。基于干细胞疗法的初步研究引起了人们的注意。第一个通过maxi-K通道治疗ED的基因转移临床试验的结果是积极的。此外,用于治疗心血管(CV)疾病的基因和干细胞疗法已有进展。目的:增进对心血管疾病的基因和干细胞治疗的了解,重点是ED。方法:回顾当前文献。结果/结论:ED的治疗和预防可以通过基于CVD基因/细胞的治疗方法得到改善。基于基因和细胞疗法的新发现将导致ED治疗方面的新​​进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号